Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed.
    Difference
    0.0%
    Check dated 2026-01-15T05:07:52.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A consolidated 'Locations' section has been added, listing recruitment sites in Illinois (USA) and in British Columbia, Ontario, and Quebec (Canada). The previous separate 'Locations' subsections and the 'HHS Vulnerability Disclosure' link have been removed.
    Difference
    0.5%
    Check dated 2025-12-17T19:00:53.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0 on the page, indicating a minor metadata update. There are no visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2025-11-26T13:54:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added related topics 'Ovarian cancer' and 'MedlinePlus Genetics' to the page. Removed a government funding/operating status notice.
    Difference
    0.5%
    Check dated 2025-11-18T22:51:09.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Ovarian cancer and related MedlinePlus Genetics topics were removed from the MedlinePlus related topics section.
    Difference
    0.1%
    Check dated 2025-11-11T20:27:47.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    Last update timestamp for the study record was refreshed; core study content such as eligibility, treatment arms, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:08:17.000Z thumbnail image

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.